Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
US-10416166-B2 · Sep 17, 2019 · US
US11150248B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11150248-B2 |
| Application number | US-201716314554-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 19, 2017 |
| Priority date | Jul 1, 2016 |
| Publication date | Oct 19, 2021 |
| Grant date | Oct 19, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods for preparing labeled glycosylamines from a complex matrix are provided. The methodology includes the steps of: denaturing glycoproteins in a complex matrix to form a denatured complex matrix mixture; loading the denatured complex matrix mixture onto a MWCO filtration device; adding a glycosidase enzymatic solution onto the MWCO filtration device to form a deglycosylated complex matrix mixture comprising glycosylamines; collecting glycosylamines released from the MWCO filtration device; and derivatizing glycosylamines with a rapid tagging reagent to form a plurality of labeled glycosylamines suitable for detection in various liquid chromatography systems and detectors.
Opening claim text (preview).
I claim: 1. A method for preparing labeled glycosylamines from a complex matrix, comprising the steps of: denaturing glycoproteins in a complex matrix by mixing the complex matrix with a denaturing solution comprising a buffer and a surfactant and heating to form a denatured complex matrix mixture; diluting and loading the denatured complex matrix mixture onto a MWCO filtration device and filtering the denatured complex matrix mixture; subsequently adding a glycosidase enzymatic solution comprising a glycosidase enzyme and a non-nucleophilic buffer compound onto the MWCO filtration device, containing the diluted denatured complex matrix mixture, and incubating the MWCO filtration device wherein the glycoproteins on the MWCO filtration device are deglycosylated and form a deglycosylated complex matrix mixture comprising glycosylamines; collecting glycosylamines released from the MWCO filtration device; and derivatizing glycosylamines with a rapid tagging reagent to form a plurality of labeled glycosylamines. 2. The method of claim 1 , wherein the MWCO filtration device is heated. 3. The method of claim 1 , wherein the denatured complex matrix mixture is loaded onto the MWCO filtration device by a liquid handling system. 4. The method of claim 1 , further comprising the step of centrifuging the denatured complex matrix mixture. 5. The method of claim 1 , further comprising the step of diluting the deglycosylated complex matrix mixture. 6. The method of claim 1 , wherein the glycosylamines flow through the MWCO filtration device to a filtrate collection device. 7. The method of claim 1 , wherein the plurality of labeled glycosylamines are detected in a liquid chromatography system. 8. The method of claim 1 , wherein the MWCO filtration device is a 96-well filter plate. 9. The method of claim 1 , wherein the complex mixture is selected from plasma, cellular lysates, biofluids and/or tissue extracts. 10. The method of claim 1 , wherein the non-nucleophilic buffer compound is a zwitterionic non-nucleophilic buffer compound and wherein the buffer compound has a pKa between about 7 and about 9. 11. The method of claim 1 , wherein the non-nucleophilic buffer compound is a non-nucleophilic cationic buffer compound. 12. The method of claim 1 , further comprising analyzing the plurality of labeled glycosylamines by mass spectrometric detection. 13. The method of claim 1 , wherein the denaturing solution further comprises a thiol reducing agent in a concentration between 1 to 100 mM. 14. A method for preparing labeled glycosylamines from a complex matrix, comprising the steps of: denaturing glycoproteins in a complex matrix by mixing the complex matrix with a denaturing solution comprising a buffer, a thiol reducing agent in a concentration between 1 to 100 mM, and a surfactant and heating to form a denatured complex matrix mixture; diluting and loading the denatured complex matrix mixture onto a MWCO filtration device and filtering the denatured complex matrix mixture; subsequently adding a glycosidase enzymatic solution comprising a glycosidase enzyme and a non-nucleophilic zwitterionic buffer compound having a pKa between about 7 and about 9 or a non-nucleophilic cationic buffer compound onto the MWCO filtration device, containing the diluted denatured complex matrix mixture, and incubating the MWCO filtration device wherein the glycoproteins on the MWCO filtration device are deglycosylated and form a deglycosylated complex matrix mixture comprising glycosylamines; collecting glycosylamines released from the MWCO filtration device; and derivatizing glycosylamines with a rapid tagging reagent to form a plurality of labeled glycosylamines. 15. The method of claim 14 , wherein the glycosidase enzymatic solution comprises the non-nucleophilic zwitterionic buffer compound having a pKa between about 7 and about 9. 16. The method of claim 14 , wherein the non-nucleophilic cationic buffer compound.
Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins · CPC title
Preparation · CPC title
N-glycosides · CPC title
by a combination of two or more processes of different types · CPC title
Labelling of peptides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.